Enterprise technology vendors are racing to make AI work against the structured and relational data inside databases, data ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...

Rosalind, a biological language model for target discovery and genomics. Currently only available for US corporate customers.

By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

Intelligence without integrity is just sophisticated risk. To build AI that lasts, you have to apply zero-trust principles to ...

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

The next important milestone for AI research is to automate model development. Every advance in reasoning, language, and perception is, in some sense, a step toward that goal. However, the path to ...

Tech stock declines highlight unsustainable AI spending; EssentaTor proposes Mapping Mathematics for durable, efficient intelligence systems.